|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Research and development expenses | |||||
| Selling, general, and administrative expenses | |||||
| Operating profit/(loss) | |||||
| Share of profit/(loss) of associates | |||||
| Finance income | |||||
| Finance expenses | |||||
| Profit/(loss) before tax | |||||
| Income taxes (expenses) | |||||
| Net profit/(loss) for the year | |||||
| Items that may be reclassified subsequently to profit or (loss): | |||||
| Exchange differences on translating foreign operations | |||||
| Other comprehensive income/(loss) for the year, net of tax | |||||
| Total comprehensive income/(loss) | |||||
| Attributable to owners of the Company | |||||
| Attributable to owners of the Company | |||||
| Basic earnings/(loss) per share | |||||
| Diluted earnings/(loss) per share | |||||
| Number of shares used for calculation (basic and diluted) |
Loading...
